Decreased gastrointestinal motility
Drug | Drug Name | Drug Description |
---|---|---|
DB09018 | Bromopride | A substituted benzamide, closely related to metoclopramide, used as an antiemetic. |
DB08810 | Cinitapride | A benzamide with gastroprokinetic and antiemetic properties typically used for the treatment of gastrointestinal motility disorders such as gastroesophageal reflux disease (GERD), non-ulcer dyspepsia, and delayed gastric emptying. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09018 | Bromopride | Dopamine D2 receptor | target |
DB08810 | Cinitapride | 5-hydroxytryptamine receptor 1A | target |
DB08810 | Cinitapride | 5-hydroxytryptamine receptor 4 | target |
DB08810 | Cinitapride | 5-hydroxytryptamine receptor 2A | target |
Drug | Drug Name | Phase | Status | Count |
---|